创兴银行(01111.HK)发行2.5亿美元5.5厘无到期日非累计後偿额外一级资本证券
创兴银行(01111.HK)公布,该行与中银国际亚洲有限公司、民银证券有限公司、招银国际融资有限公司、中信里昂证券有限公司、越秀证券有限公司、创兴银行有限公司、农银国际融资有限公司及建银国际金融有限公司订立认购协议。根据认购协议,该行将发行 2.5亿美元5.5%无到期日非累计後偿额外一级资本证券。在达致若干先决条件後,建议发行预计将於2020年8月3日完成。
该行已获悉,其最终母公司广州越秀集团股份有限公司拟按与适用於该等证券的所有其他投资者相同的条款及条件认购本金额最多2,500万美元的证券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.